The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
November 21st 2024
The risk of developing interstitial lung disease after immunotherapy was 6.5 times higher in individuals with high inflammation.
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
July 23rd 2024Following President Joe Biden’s decision to step down from re-election, VP Kamala Harris has stepped into the Democratic nominee position after support and endorsements from notable delegates and the president himself.
Read More
Pharmacist-Led DOAC Monitoring Improves Dosing
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.
Read More
Weighing In on the Recommendations for Oral Anticoagulant Use Following Bariatric Surgery
July 18th 2024Anatomical alterations result in many downstream changes, such as changes in pH, gastric volume, food intake, surface area for absorption, gastric emptying and transit times, and intestinal enzymes and efflux pumps, among others.
Read More
Study Finds 1 in 10 Pregnant Individuals Who Test Positive For COVID-19 Will Develop Long COVID
July 17th 2024The investigators note that the high prevalence of long COVID, including in pregnant individuals, emphasizes a need for health care professionals and patients to closely monitor symptoms.
Read More
Severe Pemphigus Vulgaris Successfully Treated With Intravenous Immunoglobulin
July 17th 2024A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.
Read More
Comparison Shows Eligibility for Vericiguat Wider Than Expected for Heart Failure
July 17th 2024Investigators compared the criteria for eligibility in the VICTORIA trial with guideline and label criterion, finding a wider than expected population with heart failure were eligible for vericiguat therapy.
Read More